✦ LIBER ✦

Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies

✍ Scribed by Howard Lee; Han-Mo Yang; Hae-Young Lee; Jae-Joong Kim; Dong-Ju Choi; Ki-Bae Seung; Eun-Seok Jeon; Jong-Won Ha; Se-Joong Rim; Jeong Bae Park; Joon-Han Shin; Byung-Hee Oh

Book ID: 113544698
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 843 KB
Volume: 34
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2012.04.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and tolerability of du

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

✍ Hee Chul Eun; Oh Sang Kwon; Je Ho Yeon; Hyo Seung Shin; Byung Yoon Kim; Byung In 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 555 KB

Efficacy and tolerability of nebivolol m

Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension

✍ F. Wilford Germino 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

346 EFFICACY AND SAFETY OF TEVERELIX LA,

346 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 60 MG AT 48 HOURS INTERVAL ADMINISTERED S.C. TO TREATMENT NAÏVE PATIENTS SUFFERING FROM BPH

✍ C. Maclean; F. Larsen; J. Drewe; A.V. Dzmitryieu; A. Gres; A. Strockyi; V. Dovge 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 332 KB

EFFICACY AND SAFETY OF TEVERELIX LA, A N

EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 30 MG OR 60 MG (SEPARATED BY AT LEAST 12 WEEKS) ADMINISTERED SC TO TREATMENT NAIVE PATIENTS SUFFERING FROM BPH

✍ C.M. Maclean; L. Skillern; F. Larsen; A. Gres; A. Strotski; A.V. Dmitrijev; V.K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB